Cytel
Cytel is the largest provider of statistical software and advanced analytics for clinical trial design and execution. For over thirty years, Cytel’s scientific rigor and operational excellence have helped biotech and pharmaceutical companies navigate uncertainty, prove value and unlock the full potential of their data.
East Horizon
Cytel HEOR & RWE peer reviewed publications
Cytel LiveSLR™
Cytel - Designed for Results
My Cytel Federated Single Sign On - Cytel Portal
Introduction to Population Enrichment Trial Designs
Head to Head Comparisons Using Real World Data
Practical Model-based Approaches for Phase 1 Oncology Trials
Synthetic Controls In Clinical Trials
Group Sequential Designs and Sample Size Re-estimation - Modern Uses
Bayesian Approaches to Address Clinical Development Challenges for COVID-19 Vaccine/Drugs/Devices
Innovative Drug Development at a Glance - The Concepts, The Vision, & The Factors to Consider
Study Designs for Oncology and Rare Diseases
Refocus your Enrollment to the Subpopulation of Interest with ENRICH
Optimizing Market Access for Medical Devices
Conducting Sample Size Reassessment with Time-to-event Endpoints
New Opportunities & Implications for the Future of Drug Development in Emerging Economies
Phase 2 Dose-finding Studies with MCP and Modelling Techniques
A Clinician's Perspective on Cancer Drug Development
COVID-19 Trials, Designs, and Tools for Promising Results
Phase 1 Dose Escalation Trials with ESCALATE
Transparent Machine Learning